Sign in

CIK 0001604464

  • Non-accelerated filer
  • Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460920988
Phone
+1 805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
  1. 4/A Open-market sale Chief Tech. Operations Officer sold 500 shares at $38.44 ($19,220)
  2. 4 Grant or award Chief Financial Officer acquired 10,000 shares (grant or award)
  3. 4 Grant or award Senior VP & General Counsel acquired 10,000 shares (grant or award)
  4. 4 Grant or award Chief Tech. Operations Officer acquired 15,000 shares (grant or award)
  5. 4 Grant or award Global Head of R&D acquired 15,000 shares (grant or award)
  6. 4 Grant or award SVP, Head of Global Commercial acquired 10,000 shares (grant or award)
  7. 4 Open-market sale Director sold 20,000 shares at $38.25 ($765,000)
  8. 4 Open-market sale Chief Executive Officer sold 7,800 shares at an average $39.48 ($307,953)
  9. 4 Open-market sale Chief Tech. Operations Officer sold 1,500 shares at an average $36.13 ($54,202)
  10. 4 Open-market sale Chief Executive Officer sold 7,800 shares at an average $36.14 ($281,891)
  11. 4 Open-market sale Director sold 62,590 shares at $36.07 ($2,257,621)
  12. 4/A Grant or award Director acquired 1,500 shares (grant or award)
  13. 4 Open-market sale EVP, R&D & Chief Scientific Of sold 775 shares at $39.59 ($30,682)
  14. 4 Shares withheld for taxes Chief Executive Officer gave up 1,176 shares (to pay taxes)
  15. 4 Open-market sale SVP, Head of Global Commercial sold 5,909 shares at $40.00 ($236,360)
  16. 4 Open-market sale Chief Executive Officer sold 7,800 shares at an average $38.77 ($302,367)
  17. 4/A Shares withheld for taxes Chief Executive Officer gave up 24,683 shares (to pay taxes)
  18. 4 Open-market sale EVP, R&D & Chief Scientific Of sold 13,975 shares at $38.55 ($538,736)
  19. 4 Grant or award Chief Financial Officer acquired 17,063 shares (grant or award)
  20. 4 Open-market sale EVP, R&D & Chief Scientific Of sold 12,375 shares at an average $38.62 ($477,922)

Page 14 of 33 · 645 filings